Leukotriene receptor antagonists: useful in acute asthma?

Kuitert, L. M.; Barnes, N. C.
April 2000
Thorax;Apr2000, p255
Academic Journal
No abstract available.


Related Articles

  • Montelukast beneficial in asthma exacerbations.  // Pulse;10/27/2010, Vol. 70 Issue 32, p9 

    The article discusses a study conducted in Great Britain which suggests the use of leukotriene receptor antagonists during acute asthma exacerbations.

  • montelukast. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p513 

    An encyclopedia entry for "montelukast" is presented. It is a specific leukotriene receptor antagonist drug used in the management of asthma. It is not used to treat acute asthma attacks.

  • Leukotriene modifiers in the treatment of asthma. Sampson, Anthony; Holgate, Stephen // BMJ: British Medical Journal (International Edition);04/25/98, Vol. 316 Issue 7140, p1257 

    Editorial. Looks at the treatment of asthma with the use of leukotriene modifiers. Reference to leukotriene synthesis inhibitors and cysteinyl leukotriene receptor antagonists, which are the two types of leukotriene modifiers; Detailed information on the two leukotriene modifiers; Relation to...

  • zafirlukast. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p814 

    A definition of the term "zafirlukast" is presented. It refers to a leukotriene receptor antagonist. Zafirlukast is used in asthma prevention.

  • Leukotriene receptor antagonists as add-on therapy for adults with asthma. Thomson, N.C.; Shepherd, M. // Thorax;Mar2003, Vol. 58 Issue 3, p190 

    Editorial. Examines the use of leukotriene receptor antagonists as add-on therapy for adults with moderate to severe asthma. Challenges in moderate and severe persistent asthma; Recommendations from asthma guidelines on the use of leukotriene receptor antagonists; Safety of the antagonists.

  • New drug hope for child asthma.  // Pulse;6/8/2006, Vol. 66 Issue 23, p2 

    The article talks about leukotriene receptor antagonist as a means of controlling symptoms in children with mild asthma. According to a study of general practice in Great Britain, it is substantially better to use a leukotriene receptor antagonist than inhaled steroids in controlling the...

  • Zafirlukast shows promise in asthma treatment. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;06/25/97, Vol. 10 Issue 6, p24 

    Examines the potentials of Zafirlukast, a sulfidopeptide leukotriene receptor antagonists, in asthma treatment. Need for less albuterol in patients treated with Zafirlukast; Occurrence of fewer symptoms and fewer acute attacks.

  • leukotriene receptor antagonists. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p466 

    An encyclopedia entry for "leukotriene receptor antagonists" is presented. It refers to a group of antiallergy drugs administered to prevent the symptoms of mild to moderate asthma. Leukotriene receptor antagonists work by blocking the effects of leukotrienes. Adverse events associated with...

  • zafirlukast.  // Royal Society of Medicine: Medicines;2002, p574 

    This article presents information on the drug zafirlukast. This drug can be used for the treatment of asthma to prevent mild to moderate attacks, but not to treat acute attacks. It represents a new drug class called leukotriene-receptor antagonist drugs which work as agents by blocking the...

  • Side Effects of Leukotriene Receptor Antagonists in Asthmatic Children. Erdem, Semiha Bahceci; Nacaroglu, Hikmet Tekin; Karkiner, Canan Sule Unsal; Gunay, Ilker; Can, Demet // Iranian Journal of Pediatrics;Oct2015, Vol. 25 Issue 5, p1 

    The article focuses on a study related to side-effects of leukotriene receptor antagonists in children suffering from asthma. Topics discussed include observation after discontinuation of drugs in patients with side-effects which disappeared entirely, use of anti-inflammatory therapy in asthma...


Read the Article


Sign out of this library

Other Topics